A Study of Participants With Squamous Cell Oesophageal Carcinoma Receiving Nivolumab as Part of an Early Access to Medicines Scheme (EAMS) Program in the United Kingdom
Clinical trial NCT04936399 · COMPLETED
Trial details
- NCT number
- NCT04936399
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-06-25
- Primary completion
- 2021-12-03
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.